IMPEDE Embolization Plug
Commercial- Indications
- Peripheral vascular disease
Company intelligence / Profile preview
Shape Memory Medical has commercialized shape memory polymer-based embolic devices approved in over 25 countries. Its IMPEDE® Embolization Plug family and TrelliX® Embolic Coil are used to treat peripheral vascular and neurovascular conditions. The company’s lead investigational program, IMPEDE-FX RapidFill®, is currently being evaluated in a pivotal randomized controlled trial ("AAA-SHAPE") to improve outcomes after endovascular repair of abdominal aortic aneurysms. Early clinical data support rapid clot formation, durable vessel occlusion, bioabsorption without chronic inflammation, and promotion of healthy tissue growth.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shape Memory Medical.